Patent · US Active

Management of ischemia using pooled mesenchymal stromal cell composition

US10471101B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

STEMPEUTICS RESEARCH PRIVATE LIMITED · IN

Inventors

Anish Sen Majumdar · Mumbai, IN
Pawan Kumar Gupta · Bengaluru, IN
Anoop Chullikana House · Bengaluru, IN
Sudha BALASUBRAMANIAN · Bengaluru, IN
Charan Thej · Bengaluru, IN
Mathiyazhagan RENGASAMY · Bengaluru, IN

Key dates

Filing date	Mar 25, 2015
Grant date	Nov 12, 2019
Priority date	—
Expiry date	Mar 25, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2502/1394
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to composition comprising pooled and expanded allogeneic mesenchymal Stromal cells (MSCs) and a method for management of Ischemia using the composition thereof. In particular, the disclosure relates to bone marrow derived pooled and expanded allogeneic MSC compositions with effective dosage ranges and modes/route of administration for effective management of Ischemia. The disclosure also relates to the use of conditioned medium rich in bioactive factors in combination with the cell composition for managing ischemic conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.